Vax-Before-Travel
Search
Inline CSS
Clinical Trials
Lab Tests
Subscribe
Trials
Labs
Subscribe
Home
Appointments
Destinations
Discounts
News
Outbreaks
Vaccines
Beyfortus (Nirsevimab) RSV Antibody 2023
Beyfortus (Nirsevimab) RSV Antibody 2023
Fact checked by
Robert Carlson, MD
Nov 29
3 min read
U.S. Government Wants Additional RSV Passive Immunization Supply
Beyfortus offers infants passive immunization against RSV
Respiratory Syncytial Virus (RSV)
Fact checked by
Robert Carlson, MD
Oct 15
3 min read
3.4% of Expecting Mothers Infected With RSV
RSV antibody and vaccine approved by US FDA and CDC
Respiratory Syncytial Virus (RSV)
Fact checked by
Robert Carlson, MD
Aug 22
3 min read
Expecting Mothers Have RSV Prevention Options
RSV vaccines and antibody therapeutics generate immunity in infants
Respiratory Syncytial Virus (RSV)
Fact checked by
Robert Carlson, MD
Aug 15
2 min read
RSV Can Infect Healthy Infants
Beyfortus Nirsevimab-alip is an extended half-life monoclonal antibody
Respiratory Syncytial Virus (RSV)
Fact checked by
Robert Carlson, MD
Jul 24
4 min read
$9 Billion RSV Vaccine Market Share Battle Begins
RSV vaccines and antibody therapy approved in 2023
Respiratory Syncytial Virus (RSV)
Show more
